Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis ; volume:2 ; number:1 ; day:10 ; month:9 ; year:2013 ; pages:1-5 ; date:12.2013
Systematic Reviews ; 2, Heft 1 (10.9.2013), 1-5, 12.2013
- Urheber
-
Tricco, Andrea C.
- Beteiligte Personen und Organisationen
-
Ashoor, Huda M.
Soobiah, Charlene
Hemmelgarn, Brenda
Moher, David
Hutton, Brian
Yu, Catherine H.
Majumdar, Sumit R.
Straus, Sharon E.
SpringerLink (Online service)
- DOI
-
10.1186/2046-4053-2-73
- URN
-
urn:nbn:de:1111-201607117559
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tricco, Andrea C.
- Ashoor, Huda M.
- Soobiah, Charlene
- Hemmelgarn, Brenda
- Moher, David
- Hutton, Brian
- Yu, Catherine H.
- Majumdar, Sumit R.
- Straus, Sharon E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
How can we improve the interpretation of systematic reviews?
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
How can we improve the interpretation of systematic reviews?
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review
How can we improve the interpretation of systematic reviews?
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison